|
Bi-weekly Member Newsletter
July 7, 2017
|
Keep up-to-date with the latest legislative and regulatory news. Visit
IACP's website.
Archived
Capitol Connections
newsletters here. Send your suggestions and questions to
[email protected]
.
|
|
IACP/About
IACP Member Town Hall - Meet Your New EVP on Wednesday, July 12th at 11 am CENTRAL. Join IACP's President Baylor Rice, RPh, FIACP, as he announces IACP's New Executive Vice President! Hear the latest updates on the new House Compounding Bill HR 2871, next steps and how you and your patients can get involved to protect vital access to compounded medications! Call-in instructions here.
Keep the Momentum Going - please Contribute to IACP's One Fund. Make the donation that will help preserve patient access to compounded medications and help support IACP's HR 2871 efforts. IACP is working to Protect, Promote & Advance Pharmacy Compounding.
Now thru August - Sign Up your Staff for 25% off NEW IACP Memberships. New Staff Compounding Pharmacist, Non-Compounding Pharmacist/Retired/Full-Time Faculty, Technician and Friends of Compounding memberships. Use code CCH25, click here to save!
|
|
Federal Advocacy
Ask Your Representatives to Cosponsor HR 2871: The Preserving Patient Access to Compounded Medications Act! It will only take a few minutes with IACP's easy-to-use Voter Voice action alert platform. Send a direct communication to your Representative. This important bill will help protect access to compounded medications on which your patients rely. It will help clarify the Drug Quality & Security Act (DQSA) in a way that will better align the statute with congressional intent and better balance public safety and patient access. Act, Today!
DQSA Coalition sends letter to U.S. Health & Human Services Secretary Tom Price, MD, expressing continuing serious concerns with the FDA's implementation of the Drug Quality and Security Act (DQSA). The Coalition seeks Secretary Price's assistance in both ensuring patients have continued access to vital therapeutic options provided by compounded medications, and that FDA implements the DQSA in the manner intended by Congress. The Coalition has requested a formal meeting with Secretary Price to further discuss these issues.
IACP's Congressional Recess Packet will provide you with the tools you need to host a successful congressional district visit as the 115th U.S. Congress goes on summer recess, July 31 - September 4, 2017. Stay tuned for an IACP email next week providing you with everything you need to plan a successful congressional visit!
|
|
|
Click here to send a direct message to your Representatives:
Support HR 2871
!
|
|
|
State Advocacy
Compounders Stateside is IACP's members-only one-stop resource for state legislative and regulatory updates! Be sure to visit weekly for the latest activity in your state.
Compounders Stateside is an exclusive IACP benefit - you will need to log in to access.
- California Members - State Board of Pharmacy Enforcement and Compounding Committee Meeting scheduled for July 12th.
|
|
Grassroots
Urge your patients and physicians to join the effort to protect patient access to compounded medications! Let's Educate, Advocate, Protect & Advance Patients' Access to
Customized Medications.
|
Events & Education Update
|
|
|
|
Attendee Advanced Registration Discount Ends Wednesday, August 2, 2017 at MIDNIGHT!
|
Save the Date for IACP's Educational Conference, January 24-27, 2018, at the beautiful Sonesta Fort Lauderdale Beach in Florida! Obtain CE by the SEA, and network with your colleagues as IACP brings you unique programming no one else can provide!
What you can expect in 2018:
- Choose from a variety of CE contact hours focusing on hot-button topics such as pharmacy law, USP Chapter <800>, legislative/regulatory updates, and marketing;
- Visit with Exhibitors showcasing services that can improve your business;
- Network with your colleagues in a beautiful beach setting - with CE education in the morning, and resort activities in the afternoon. Enjoy the best of both worlds in one conference.
|
|
Corporate Partner Spotlight: PCCA
Support neuro-health, one patient at a time.
Synapsin was developed by renowned author, pharmacist and functional medicine speaker Jim LaValle, RPh, CCN, ND. It is an ingredient designed to be used in dietary supplement formulations for patients who could benefit from neural and cognitive support,* and it's
now available exclusively from PCCA
. More information here!
|
|
|
|
